Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries - 09/09/11
Abstract |
Experimental studies have implicated a functional role for the extracellular matrix glycoprotein thrombospondin-1 (TSP-1) in vascular smooth muscle cell proliferation and migration. We therefore sought to determine if TSP-1 might represent a specific component of the fibroproliferative tissue typically associated with restenosis lesions from human coronary and peripheral arteries. Positive immunostaining for TSP-1 was limited to hypocellular plaques typical of primary atherosclerosis; in contrast, such staining was nearly absent from the loose extracellular matrix of the fibroproliferative tissue typical of restenotic lesions. Only a small fraction of vascular smooth muscle cells in either primary or restenotic lesions demonstrated a cellular staining pattern for TSP-1, which was also observed in control studies performed in cell culture and in atherosclerotic rabbit arteries examined 3 days after experimental balloon angioplasty. Double-staining for TSP-1 and proliferating cell nuclear antigen in studies of human beings disclosed that only a small portion of proliferating cell nuclear antigen-positive cells also stained for TSP-1. The observations made in this series of specimens thus indicate that TSP-1 is not a major component of the extracellular matrix of human restenotic tissues, even when such specimens demonstrate evidence of hypercellularity or ongoing cellular proliferation. Because most restenosis specimens, however, were retrieved ≥1 month after the primary intervention, a functional role for TSP-1 in smooth muscle cell proliferation or migration at the early stages of lesion development is still possible. (Am Heart J 1998;135:357-64.)
Le texte complet de cet article est disponible en PDF.Plan
From the aDepartments of Medicine (Cardiology) and Biomedical Research, St. Elizabeth's Medical Center, Tufts University School of Medicine, and the bVascular Research Division, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School. |
|
Supported in part by grants (HL 02824, Academic Award in Vascular Medicine; HL 40518 [both J.M.I. and H.L.] 28749 [J.L.]) from the National Heart Lung and Blood Institute, National Institutes of Health. RR was a recipient of a grant from the Deutsche Forschungsgemeinschaft. |
|
Reprint requests: Jeffrey M. Isner, MD, St. Elizabeth's Medical Center, 736 Cambridge St., Boston, MA 02135. |
|
E-mail: jisner@opal.tufts.edu |
|
♢ | 4/1/86033 |
Vol 135 - N° 2
P. 357-364 - février 1998 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?